Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials
-
* Corresponding author: Don Husereau donh@ccohta.ca
- Equal contributors
1 Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 600-865 Carling Avenue, Ottawa ON K1S 5S8, Canada
2 Health Research Institute, University of Ottawa, Ottawa ON K1H 8L6, Canada
BMC Pulmonary Medicine 2004, 4:7 doi:10.1186/1471-2466-4-7
Published: 31 August 2004Additional files
Additional File 1:
Appendix 1. A list of reports considered in this review but excluded.
Format: PDF Size: 143KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional File 2:
Appendix 2. Search strategies including databases, time horizons and subject headings/keywords used to locate trials.
Format: PDF Size: 52KB Download file
This file can be viewed with: Adobe Acrobat Reader
